VICP Registry Case Source Bundle
Canonical URL: https://vicp-registry.org/case/USCOURTS-cofc-1_22-vv-00830
Package ID: USCOURTS-cofc-1_22-vv-00830
Petitioner: Osmyn Lavor Deuel
Filed: 2022-07-28
Decided: 2025-04-01
Vaccine: Tdap
Vaccination date: 2019-08-01
Condition: Guillain-Barré Syndrome (GBS) or chronic inflammatory demyelinating polyradiculoneuropathy (CIDP)
Outcome: compensated
Award amount USD: 80000

AI-assisted case summary:
Osmyn Lavor Deuel filed a petition on July 28, 2022, alleging that the tetanus-diphtheria-acellular pertussis (Tdap) vaccine he received on August 1, 2019, caused him to suffer from Guillain-Barré Syndrome (GBS) or chronic inflammatory demyelinating polyradiculoneuropathy (CIDP). The Tdap vaccine is listed on the Vaccine Injury Table. Respondent denied that the vaccine caused Mr. Deuel's condition but agreed to a joint stipulation for compensation. The parties stipulated to an award of $80,000.00 to compensate Mr. Deuel for all damages available under the program. Special Master Christian J. Moran found the stipulation reasonable and adopted it as the decision of the Court, directing that judgment be entered accordingly. The public decision does not describe the onset of symptoms, specific medical tests, treatments, or expert witnesses. Petitioner was represented by David Charles Richards of Christensen & Jensen, P.C., and Respondent was represented by Nina Ren of the United States Department of Justice.

Theory of causation field:
Petitioner Osmyn Lavor Deuel alleged that the Tdap vaccine received on August 1, 2019, caused Guillain-Barré Syndrome (GBS) or chronic inflammatory demyelinating polyradiculoneuropathy (CIDP). The Tdap vaccine is listed on the Vaccine Injury Table. Respondent denied causation. The parties entered into a joint stipulation for compensation, agreeing to an award of $80,000.00 for all damages. Special Master Christian J. Moran adopted the stipulation as the decision of the Court on April 1, 2025. The public decision does not detail the specific mechanism of causation, expert testimony, or the breakdown of damages beyond the lump sum. Petitioner's counsel was David Charles Richards, and Respondent's counsel was Nina Ren.

Public staged source text:

================================================================================
DOCUMENT 1: USCOURTS-cofc-1_22-vv-00830-0
Date issued/filed: 2025-04-22
Pages: 7
Docket text: PUBLIC DECISION (Originally filed: 04/01/2025) regarding 62 DECISION Stipulation/Proffer. Signed by Special Master Christian J. Moran. (jjb) Service on parties made.
--------------------------------------------------------------------------------
Case 1:22-vv-00830-UNJ Document 67 Filed 04/22/25 Page 1 of 7
In the United States Court of Federal Claims
OFFICE OF SPECIAL MASTERS
* * * * * * * * * * * * * * * * * * * * * * * * *
OSMYN LAVOR DEUEL, *
* No. 22-830V
*
*
Petitioner, * Special Master Christian J. Moran
*
v. *
* Filed: April 1, 2025
SECRETARY OF HEALTH *
AND HUMAN SERVICES, *
*
Respondent. *
* * * * * * * * * * * * * * * * * * * * * * * * *
David Charles Richards, Christensen & Jensen, P.C., Salt Lake City, UT, for
Petitioner;
Nina Ren, United States Dep’t of Justice, Washington, DC, for Respondent.
UNPUBLISHED DECISION1
On April 1, 2025, the parties filed a joint stipulation concerning the petition
for compensation filed by Osmyn Lavor Deuel on July 28, 2022. Petitioner
alleged that the tetanus-diphtheria-acellular pertussis (“Tdap”) vaccine he received
on August 1, 2019, which is contained in the Vaccine Injury Table (the “Table”),
42 C.F.R. §100.3(a), caused Mr. Deuel to suffer from Guillain-Barré Syndrome
(“GBS”) or chronic inflammatory demyelinating polyradiculoneuropathy
(“CIDP”). Petitioner represents that there has been no prior award or settlement of
1 Because this Decision contains a reasoned explanation for the action taken in this case,
it must be made publicly accessible and will be posted on the United States Court of Federal
Claims' website, and/or at https://www.govinfo.gov/app/collection/uscourts/national/cofc, in
accordance with the E-Government Act of 2002. 44 U.S.C. § 3501 note (2018) (Federal
Management and Promotion of Electronic Government Services). This means the Decision will
be available to anyone with access to the internet. In accordance with Vaccine Rule 18(b), the
parties have 14 days to identify and move to redact medical or other information, the disclosure
of which would constitute an unwarranted invasion of privacy. Any changes will appear in the
document posted on the website.

Case 1:22-vv-00830-UNJ Document 67 Filed 04/22/25 Page 2 of 7
a civil action for damages on Mr. Deuel’s behalf as a result of Mr. Deuel’s
condition.
Respondent denies that Mr. Deuel’s alleged GBS or CIDP were caused-in-
fact by the Tdap vaccine; and denies that the Tdap vaccine caused Mr. Deuel any
other injury or Mr. Deuel’s current condition. Nevertheless, the parties agree to
the joint stipulation, attached hereto. The undersigned finds said stipulation
reasonable and adopts it as the decision of the Court in awarding damages, on the
terms set forth therein.
Damages awarded in that stipulation include:
A lump sum of $80,000.00 to be paid through an ACH deposit to
petitioner’s counsel’s IOLTA account for prompt disbursement to
petitioner.
This amount represents compensation for all damages that would be
available under 42 U.S.C. § 300aa-15(a).
In the absence of a motion for review filed pursuant to RCFC, Appendix B,
the clerk is directed to enter judgment according to this decision and the attached
stipulation.2
IT IS SO ORDERED.
s/Christian J. Moran
Christian J. Moran
Special Master
2 Pursuant to Vaccine Rule 11(a), the parties can expedite entry of judgment by each
party filing a notice renouncing the right to seek review by a United States Court of Federal
Claims judge.
2

Case 1:22-vv-00830-UNJ Document 67 Filed 04/22/25 Page 3 of 7

Case 1:22-vv-00830-UNJ Document 67 Filed 04/22/25 Page 4 of 7

Case 1:22-vv-00830-UNJ Document 67 Filed 04/22/25 Page 5 of 7

Case 1:22-vv-00830-UNJ Document 67 Filed 04/22/25 Page 6 of 7

Case 1:22-vv-00830-UNJ Document 67 Filed 04/22/25 Page 7 of 7